HCW Biologics Inc Share Price Today: Live Updates & Key Insights

HCW Biologics Inc share price today is $0.6775, up -1.86%. The stock opened at $0.7292 against the previous close of $0.7525, with an intraday high of $0.785 and low of $0.7.

HCW Biologics Inc Share Price Chart

HCW Biologics Inc

us-stock
To Invest in {{usstockname}}
us-stock

HCW Biologics Inc Share Price Performance

$0.6775 -0.0186(-1.86%) HCWB at 23 Mar 2026 01:26 PM Biotechnology
Lowest Today 0.7
Highest Today 0.785
Today’s Open 0.7292
Prev. Close 0.7525
52 Week High 12.80
52 Week Low 0.47
Day’s Range: Low 0.7 High 0.785
52-Week Range: Low 0.47 High 12.80
1 day return -
1 Week return -24.07
1 month return +23.26
3 month return -55.02
6 month return -82.54
1 year return +124.87
3 year return -51.27
5 year return -88.55
10 year return -

HCW Biologics Inc Institutional Holdings

Armistice Capital, LLC 9.15

DRW Securities, LLC 2.54

Citadel Advisors Llc 0.68

Susquehanna International Group, LLP 0.61

Abante Quant Value FI 0.60

Vanguard Group Inc 0.47

Geode Capital Management, LLC 0.43

Vanguard Institutional Extnd Mkt Idx Tr 0.41

J.W. COLE ADVISORS, INC. 0.38

Golden State Wealth Management, LLC 0.30

Fidelity Extended Market Index 0.27

Tower Research Capital LLC 0.14

Spartan Extended Market Index Pool F 0.06

Wells Fargo & Co 0.05

Fidelity Series Total Market Index 0.05

Fidelity Total Market Index 0.02

Spartan Total Market Index Pool G 0.02

Fidelity Nasdaq Composite Index 0.01

Citigroup Inc 0.01

Northern Trust Extended Eq Market Idx 0.01

NT Ext Equity Mkt Idx Fd - L 0.01

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

ZWJ Balanced 0.00

State St US Extended Mkt Indx NL Cl C 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

SSgA U.S. Total Market Index Strategy 0.00

Advisor Group Holdings, Inc. 0.00

State St US Ttl Mkt Indx NL Cl A 0.00

Bank of America Corp 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

Fortitude Family Office LLC 0.00

SBI Securities Co Ltd 0.00

UBS Group AG 0.00

HCW Biologics Inc Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

HCW Biologics Inc Fundamentals

Market Cap 5.36 M

PB Ratio 2.7998

PE Ratio 0.0

Enterprise Value 9.96 M

Total Assets 30.24 M

Volume 1161560

HCW Biologics Inc Company Financials

Annual Revenue FY23:2859312 2.9M, FY22:6722090 6.7M, FY21:0 0.0M, FY20:4099750 4.1M, FY19:0 0.0M

Annual Profit FY23:576019 0.6M, FY22:2586378 2.6M, FY21:null 0.0M, FY20:4099750 4.1M, FY19:null 0.0M

Annual Net worth FY23:-19732487 -19.7M, FY22:-14722628 -14.7M, FY21:-12357102 -12.4M, FY20:-5779877 -5.8M, FY19:-7220568 -7.2M

Quarterly Revenue Q3/2025:15606 0.0M, Q2/2025:6550 0.0M, Q1/2025:5065 0.0M, Q3/2024:426423 0.4M, Q2/2024:618854 0.6M

Quarterly Profit Q3/2025:-170784 -0.2M, Q2/2025:1310 0.0M, Q1/2025:1013 0.0M, Q3/2024:85285 0.1M, Q2/2024:180411 0.2M

Quarterly Net worth Q3/2025:-4554336 -4.6M, Q2/2025:-1927730 -1.9M, Q1/2025:-2196875 -2.2M, Q3/2024:-3902288 -3.9M, Q2/2024:-15280191 -15.3M

About HCW Biologics Inc & investment objective

Company Information HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in phase 1 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201 and HCW9206, novel immunotherapeutic for memory-like natural killer cells, cancer, and pathogens; HCW11-006, an immune cell stimulator; HCW11-002 and HCW11-0027, which are immune checkpoint inhibitors to treat oncology and other senescence-associated indications; and HCW11-018, a fusions and immune cell engagers to treat cancer. The company has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecules. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

Organisation Biotechnology

Employees 36

Industry Biotechnology

CEO Dr. Hing C. Wong Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

HCW Biologics Inc FAQs

What is the share price of HCW Biologics Inc today?

The current share price of HCW Biologics Inc is $0.6775.

Can I buy HCW Biologics Inc shares in India?

Yes, Indian investors can buy HCW Biologics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy HCW Biologics Inc shares in India?

You can easily invest in HCW Biologics Inc shares from India by:

Can I buy fractional shares of HCW Biologics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of HCW Biologics Inc?

HCW Biologics Inc has a market cap of $5.36 M.

In which sector does HCW Biologics Inc belong?

HCW Biologics Inc operates in the Biotechnology sector.

What documents are required to invest in HCW Biologics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of HCW Biologics Inc?

The PE ratio of HCW Biologics Inc is N/A and the PB ratio is 2.80.